Połowa wszystkich pacjentów wypisywanych ze szpitala po zawale serca jest niepotrzebnie leczona beta-blokerami. Tak wynika z nowego badania opublikowanego w New England Journal of Medicine. Powszechną ...

Most trials that have shown a benefit of beta-blocker treatment after myocardial infarction included patients with large myocardial infarctions and were conducted in an era before modern biomarker ...

Beta-blockers (also called beta-adrenergic blockers) are drugs that are used to lower blood pressure (among other things). They do this by blocking the effects of the hormones adrenaline and ...

It has been assumed that β-AR antagonists (β-blockers) have a direct favorable influence on the heart, but our results challenge this view, suggesting that β-blockers may also act directly in ...

Beta-blockers are now a worldwide mainstay of heart failure treatment recommended in all international guidelines for chronic heart failure: this is a reversal of previous practice since they were ...

Heart attack patients are needlessly taking beta blockers even though they provide no clear benefits, a landmark trial has concluded. The daily tablets, which can trigger fatigue, nausea and even ...

Nick Blackmer is a librarian, fact-checker, and researcher with more than 20 years of experience in consumer-facing health and wellness content. The use of beta-blockers have been a gold standard ...

In a recent study published in The New England Journal of Medicine, researchers conducted the Randomized Evaluation of Decreased Usage of Beta-Blockers after Acute Myocardial Infarction (REDUCE ...

My heart sank yesterday when I saw the story about beta blockers helping ‘only half of heart attack patients’, according to a new study. Thousands of people in the UK take the drugs ...

Taking beta blockers after a heart attack did not significantly reduce the risk of death or a second heart attack among people with normal heart pumping ability, as indicated by an ejection fraction ...

A telemedicine initiative targeting patients with heart failure with reduced ejection fraction in the Navajo Nation improved rates of guideline-directed therapy by fivefold.